ZELUNATE

EUIPO EUIPO 2014 Trademark registered

The displayed mark can be extended.
Click here, to extend trademark protection for a further 10 years.

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark ZELUNATE was filed as Word mark on 03/10/2014 at the European Union Intellectual Property Office.
It was registered as a trademark on 10/09/2014. The current status of the mark is "Trademark registered".

Extend brand

Trademark Details Last update: February 9, 2024

Trademark form Word mark
File reference 012677654
Application date March 10, 2014
Publication date July 2, 2014
Entry date October 9, 2014
Expiration date March 10, 2024

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Widenmayerstr. 10 80538 München DE

goods and services

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, diagnosis, cure and prevention of alcohol use disorders, Alzheimer's and anxiety disorders; pharmaceutical preparations, namely for the treatment, diagnosis, cure and prevention of atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer and cardiovascular diseases; pharmaceutical preparations, namely for the treatment, diagnosis, cure and prevention of central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders; pharmaceutical preparations namely for the treatment, diagnosis, cure and prevention of diabetes, dyslipidemia, endocrine diseases and disorders; pharmaceutical preparations, namely for the treatment, diagnosis, cure and prevention of gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders and migraines; pharmaceutical preparations, namely for the treatment, diagnosis, cure and prevention of muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders; pharmaceutical preparations, namely for the treatment, diagnosis, cure and prevention of Parkinson's disease, psychiatric disorders, reproductive system diseases and disorders, sleep disorders and urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases; pharmaceutical and veterinary preparations

Trademark history

Date Document number Area Entry
August 13, 2023 Extension, Notification of expiry of trade mark
April 5, 2019 Change Representative, Published
December 20, 2018 Change Representative, Published

ID: 11012677654